Compare LQDA & PSMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LQDA | PSMT |
|---|---|---|
| Founded | 2004 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.6B |
| IPO Year | 2020 | 2005 |
| Metric | LQDA | PSMT |
|---|---|---|
| Price | $68.49 | $174.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $41.00 | N/A |
| AVG Volume (30 Days) | ★ 963.9K | 176.5K |
| Earning Date | 05-08-2026 | 04-08-2026 |
| Dividend Yield | N/A | ★ 0.91% |
| EPS Growth | ★ 51.81 | 5.47 |
| EPS | 1.26 | ★ 4.18 |
| Revenue | $158,320,000.00 | ★ $4,066,093,000.00 |
| Revenue This Year | $278.87 | $12.29 |
| Revenue Next Year | $57.13 | $10.70 |
| P/E Ratio | $56.31 | ★ $41.43 |
| Revenue Growth | ★ 1031.18 | 12.33 |
| 52 Week Low | $21.35 | $111.68 |
| 52 Week High | $93.61 | $199.84 |
| Indicator | LQDA | PSMT |
|---|---|---|
| Relative Strength Index (RSI) | 47.51 | 54.49 |
| Support Level | $62.86 | $166.57 |
| Resistance Level | $92.35 | $180.37 |
| Average True Range (ATR) | 2.78 | 3.78 |
| MACD | 0.69 | 1.00 |
| Stochastic Oscillator | 66.74 | 69.83 |
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
Pricesmart Inc is principally engaged in operating U.S.-style membership shopping warehouse clubs that offer consumer goods at low prices. The company is headquartered in San Diego, California, United States, and operates stores in the Caribbean, Costa Rica, Panama, and other regions. The company's revenue consists of net warehouse club sales from merchandise sales, membership income from annual membership fees, export sales, and other income. Its operations consist of four reportable segments; Central America, the Caribbean, Colombia, and the United States. A majority of the company's revenue is derived from Central America.